Targeting myeloid cells to improve cancer immune therapy

Tumor immunosuppression remains a major barrier to effective cancer immunotherapy and is often driven by the immunoregulatory activities of innate immune cells, such as myeloid cells within the tumor microenvironment (TME). Myeloid populations—including tumor-associated macrophages (TAMs), dendritic...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Hui Chen, Zihan Xu, Judith Varner
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623436/full